Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from EZZ Life Science Holdings Ltd. ( (AU:EZZ) ) is now available.
EZZ Life Science Holdings Limited has announced the date for its 2025 Annual General Meeting, which will be held on November 28, 2025. The company has also set October 17, 2025, as the closing date for director nominations. This announcement is part of EZZ’s ongoing efforts to strengthen its governance and strategic positioning in the genomic life sciences sector.
The most recent analyst rating on (AU:EZZ) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on EZZ Life Science Holdings Ltd. stock, see the AU:EZZ Stock Forecast page.
More about EZZ Life Science Holdings Ltd.
EZZ Life Science Holdings Limited is a genomic life science company focused on improving quality of life and human health. The company invests in consumer health through e-commerce and distribution of high-quality products via omnichannel models across Australia, New Zealand, China, and globally, with a strategic market entry into the United States.
Average Trading Volume: 85,428
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$112.7M
For a thorough assessment of EZZ stock, go to TipRanks’ Stock Analysis page.